Companies: 10,795·Total market cap: $144.5T

Eisai Co., Ltd.

Eisai Co., Ltd.

ESALFOTCHealthcare● Active

$28.00

+$4.12(+17.25%)

Market Cap$7.9B

P/E Ratio—

52W High$35.83

52W Low$23.88

Avg Volume69

Open$28.00

Beta-0.14

股票排行：Drug Manufacturers - Specialty & Generic·Healthcare·查看全部市值排行 →

Eisai Co., Ltd.（ESALF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ESALF · 截至 Jun 8, 2026

关键指标

EPS (TTM)$137.85Earnings history

PE Ratio (TTM)0.2×PE Ratio deep dive

Revenue (TTM)$830.7BFull revenue history

Dividend Yield3.34%Dividend history

Shares Outstanding281.9MShares outstanding history

Next EarningsJul 31, 2026Est.Earnings history

探索 Eisai Co., Ltd. 数据

分析师预测—

营收$830.6B+5.22%

盈利EPS $137.41-16.09%

财务快照

FY 2026Revenue$830.57B▲ +5.22% YoY

202420252026

FY 2026Net Income$38.80B▼ 16.44% YoY

202420252026

FY 2026EPS$137.41▼ 16.09% YoY

202420252026

TTM:Revenue: $830.66BNet Income: $38.77BEPS: $137.85View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Eisai Co., Ltd.

$28.00+17.25%$7.9B #2

Swedish Orphan Biovitrum AB (publ)

$47.35-0.26%$16.4B #3

$11.12+0.00%$7.6B #4

$8.85+0.00%$8.7B #5

Kyowa Kirin Co., Ltd.

$12.84-10.99%$6.7B #6

North Bud Farms Inc.

$0.00+0.00%$634

股票表现

1D+17.25%

1W+17.25%

1M-6.67%

3M-20.00%

YTD-5.82%

1Y+1.82%

5Y-72.00%

关于 Eisai Co., Ltd.

CEOHaruo Naito

IPO DateApr 7, 2011

Employees11,067

CountryJP

Websiteeisai.co.jp

Eisai Co., Ltd. a pharmaceutical company headquartered in Tokyo, Japan, develops and markets a wide array of medicinal products. Its offerings for neurological conditions include Aricept, prescribed …

Drug Manufacturers - Specialty & Generic HealthcareOTCJP

关于股票概览与关键数据

Eisai Co., Ltd.（ESALF）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 Apr 7, 2011 在 OTC 上市。截至最近交易日，ESALF 股价为 $28.00，市值约为 $7.9B。过去12个月累计回报 +1.82%，年初至今回报 -5.82%。

2026 财年 Eisai Co., Ltd. 营收 $830.6B。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Eisai Co., Ltd.（ESALF）股价为 $28.00，在 OTC 上市，52周区间为 $23.88 – $35.83。

ESALF 最新股价ESALF quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议